MinireviewKainic acid as a tool for the study of temporal lobe epilepsy
References (98)
- et al.
Brain Res.
(1970) - et al.
Brain Res.
(1974) - et al.
Neuroscience
(1980) - et al.
Prog. Neurobiol.
(1980) - et al.
Eur. J. Pharmacol.
(1978) - et al.
Brain Res.
(1980) - et al.
Life Sci.
(1980) - et al.
Eur. J. Pharmacol.
(1978) - et al.
Neuropharmacology
(1981) - et al.
Life Sci.
(1979)
Life Sci.
(1980)
Eur. J. Pharmacol.
(1979)
Brain Res.
(1978)
Brain Res.
(1980)
Neuropharmacology
(1978)
Neuroscience
(1980)
Brain Res.
(1979)
Neurosci. Lett.
(1980)
Brain Res.
(1979)
Neuroscience
(1980)
Brain Res.
(1978)
Life Sci.
(1979)
Brain Res.
(1980)
Brain Res.
(1979)
Exp. Neurol.
(1976)
Soc. Neurosci. Abstr.
(1979)
Epilepsy: Its Phenomena in Man
Lancet
(1974)
Brain Res.
(1980)
Neurosci. Lett.
(1978)
Neurosci. Lett.
(1978)
Brain Res.
(1980)
Brain Res.
(1978)
Brain Res.
(1980)
Neurosci. Lett.
(1980)
Neuropharmacology
(1979)
Brain Res.
(1980)
Soc. Neurosci. Abstr.
(1975)
Nature
(1978)
Kainic Acid Ass a Tool in Neurobiology
(1978)
Life Sci.
(1978)
Neurosciences Research Program Bulletin
(1981)
Psychopharmacology
(1979)
Neurosurgery
(1978)
J. Pharmacol. Exp. Ther.
(1980)
Kainic Acid As a Tool in Neurobiology
Naunyn-Schmieds. Archs. Pharmacol.
(1980)
Life Sci.
(1978)
Cited by (533)
Synapse-specific changes in Arc and BDNF in rat hippocampus following chronic temporal lobe epilepsy
2023, Neuroscience ResearchGlutamate receptor endocytosis and signaling in neurological conditions
2023, Progress in Molecular Biology and Translational ScienceXanthohumol, an active constituent from hope, affords protection against kainic acid-induced excitotoxicity in rats
2020, Neurochemistry InternationalInvolvement of monocarboxylate transporters in the cross-tolerance between epilepsy and cerebral infarction: A promising choice towards new treatments
2019, Neuroscience LettersCitation Excerpt :After 15 min of MCAO, reperfusion was performed by removing the filament. A glutamate analogue KA protocol was used to induce epilectic seizures in rats, consisting of intraperitoneal (i.p.) injections with KA (15 mg/kg) to evoke behavioral seizures known resembling human temporal lobe epilepsy [13]. The a-cyano-4-hydroxycinnamate (CHC; Sigma-Aldrich, St. Louis, MO, USA; 90 mg/kg) which is a specific covalent inhibitor of mitochondrial lactate and pyruvate transport [14] was intraperitoneal injected 4 h before KA injection.
Copyright © 1981 Published by Elsevier Inc.